Andrea Iaboni

Dr. Andrea Iaboni


Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2002 in Immunity
Verified
Journal Article
Closed access
ACAlison V. Collins
Alison V. Collins
DBDouglas W. Brodie
Douglas W. Brodie
RGRobert J.C. Gilbert
Robert J.C. Gilbert
AIAndrea Iaboni
Andrea Iaboni
RMRaquel Manso-Sancho
Raquel Manso-Sancho
SDSimon J. Davis
Simon J. Davis

5 November 2006 in Nature Methods
Verified
Journal Article
Closed access
JJJohn James
John James
MOMarta I Oliveira
Marta I Oliveira
ACAlexandre M. Carmo
Alexandre M. Carmo
AIAndrea Iaboni
Andrea Iaboni
SDSimon J Davis
Simon J Davis

1 May 2013 in The American Journal of Geriatric Psychiatry
Verified
Journal Article
Closed access
AIAndrea Iaboni
Andrea Iaboni
AFAlastair J. Flint
Alastair J. Flint

19 November 2001 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
SBShannon K. Bromley
Shannon K. Bromley
AIAndrea Iaboni
Andrea Iaboni
SDSimon J. Davis
Simon J. Davis
AWAdrian Whitty
Adrian Whitty
JGJonathan M. Green
Jonathan M. Green
MDMichael Dustin
Michael Dustin

17 February 2017 in The Canadian Journal of Psychiatry
Verified
Journal Article
Closed access
DGDamien Gallagher
Damien Gallagher
CFCorinne E. Fischer
Corinne E. Fischer
AIAndrea Iaboni
Andrea Iaboni
Objective: Neuropsychiatric symptoms (NPS) may be the first manifestation of an underlying neurocognitive disorder. We undertook a review to provide an update on the epidemiology and etiological mechanisms of NPS that occur in mild cognitive impairment (MCI) and just before the onset of MCI. We discuss common clinical presentations and the implications for diagnosis and care. Method: The authors conducted a selective review of the literature regarding the emergence of NPS in late life, before and after the onset of MCI. We discuss recent publications that explore the epidemiology and etiological mechanisms of NPS in the earliest clinical stages of these disorders. Results: NPS have been reported in 35% to 85% of adults with MCI and also occur in advance of cognitive decline. The occurrence of NPS for the first time in later life should increase suspicion for an underlying neurocognitive disorder. The presenting symptom may provide a clue regarding the etiology of the underlying disorder, and the co-occurrence of NPS may herald a more accelerated cognitive decline. Conclusions: NPS are prevalent in the early clinical stages of neurocognitive disorders and can serve as both useful diagnostic and prognostic indicators. Recognition of NPS as early manifestations of neurocognitive disorders will become increasingly important as we move towards preventative strategies and disease-modifying treatments that may be most effective when deployed in the earliest stages of disease.

25 January 2022 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
ASAndrea Sabo
Andrea Sabo
SMSina Mehdizadeh
Sina Mehdizadeh
AIAndrea Iaboni
Andrea Iaboni
BTBabak Taati
Babak Taati
Drug-induced parkinsonism affects many older adults with dementia, often causing gait disturbances. New advances in vision-based human pose- estimation have opened possibilities for frequent and unobtrusive analysis of gait in long-term care settings. This work leverages spatial-temporal graph convolutional network (ST-GCN) architectures and training procedures to predict clinical scores of parkinsonism in gait from video of individuals with dementia. We propose a two-stage training approach consisting of a self-supervised pretraining stage that encourages the ST-GCN model to learn about gait patterns before predicting clinical scores in the finetuning stage. The proposed ST-GCN models are evaluated on joint trajectories extracted from video and are compared against traditional (ordinal, linear, random forest) regression models and temporal convolutional network baselines. Three 2D human pose-estimation libraries (OpenPose, Detectron, AlphaPose) and the Microsoft Kinect (2D and 3D) are used to extract joint trajectories of 4787 natural walking bouts from 53 older adults with dementia. A subset of 399 walks from 14 participants is annotated with scores of parkinsonism severity on the gait criteria of the Unified Parkinson's Disease Rating Scale (UPDRS) and the Simpson-Angus Scale (SAS). Our results demonstrate that ST-GCN models operating on 3D joint trajectories extracted from the Kinect consistently outperform all other models and feature sets. Prediction of parkinsonism scores in natural walking bouts of unseen participants remains a challenging task, with the best models achieving macro-averaged F1-scores of 0.53 ± 0.03 and 0.40 ± 0.02 for UPDRS-gait and SAS-gait, respectively. Pre-trained model and demo code for this work is available. 1